Home > Insights > Occoris and the challenges of API-only drug delivery

Occoris and the challenges of API-only drug delivery

09 Jul 2014 1min read

Phil Canner

Past employee

At a recent Management Forum event in London, I presented Occoris and the challenges of API-only delivery.

In the 27 minute presentation I discuss the current market situation of dry powder inhalers, the challenges of delivering pure API and the opportunities for API-only inhalers.

To watch the video, please click the play button below:

Join the conversation

Looking for industry insights? Click below to get our opinions and thoughts into the world of
medical devices and healthcare.